These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4063940)

  • 1. Myoclonus, hyperreflexia and diaphoresis in patients on phenelzine-tryptophan combination treatment.
    Levy AB; Bucher P; Votolato N
    Can J Psychiatry; 1985 Oct; 30(6):434-6. PubMed ID: 4063940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.
    Pope HG; Jonas JM; Hudson JI; Kafka MP
    Am J Psychiatry; 1985 Apr; 142(4):491-2. PubMed ID: 3976924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serotoninergic syndrome after combining tramadol and iproniazid].
    de Larquier A; Vial T; Bréjoux G; Descotes J
    Therapie; 1999; 54(6):767-8. PubMed ID: 10709455
    [No Abstract]   [Full Text] [Related]  

  • 5. Case report of a toxic reaction from a combination of tryptophan and phenelzine.
    Thomas JM; Rubin EH
    Am J Psychiatry; 1984 Feb; 141(2):281-3. PubMed ID: 6691495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The behavioral toxicity of monoamine oxidase-inhibiting antidepressants.
    Murphy DL
    Adv Pharmacol Chemother; 1977; 14():71-105. PubMed ID: 18913
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam.
    Naylor MW; Grunhaus L; Cameron O
    J Nerv Ment Dis; 1987 Feb; 175(2):111-4. PubMed ID: 3806075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylaxis and monoamine oxidase inhibitors--the use of adrenaline.
    Fenwick MJ; Muwanga CL
    J Accid Emerg Med; 2000 Mar; 17(2):143-4. PubMed ID: 10718244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitation and potential hazards of MAOI's for the treatment of depressive symptoms in abstinent alcoholics.
    Schottenfeld RS; O'Malley SS; Smith L; Rounsaville BJ; Jaffe JH
    Am J Drug Alcohol Abuse; 1989; 15(3):339-44. PubMed ID: 2669469
    [No Abstract]   [Full Text] [Related]  

  • 12. Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated?
    Askenasy JJ; Yahr MD
    J Neural Transm; 1988; 72(1):67-76. PubMed ID: 3379388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and experimental aspects of interactions between amine oxidase inhibitors and amine re-uptake inhibitors.
    Marley E; Wozniak KM
    Psychol Med; 1983 Nov; 13(4):735-49. PubMed ID: 6665091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN; Brown BJ
    Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.
    Kline SS; Mauro LS; Scala-Barnett DM; Zick D
    Clin Pharm; 1989 Jul; 8(7):510-4. PubMed ID: 2568897
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug combinations in the treatment of refractory depression: a review.
    Stern SL; Mendels J
    J Clin Psychiatry; 1981 Oct; 42(10):368-73. PubMed ID: 6116699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serotonin syndrome.
    Sternbach H
    Am J Psychiatry; 1991 Jun; 148(6):705-13. PubMed ID: 2035713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH; Volkers AC; van den Broek WW; Bruijn JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract]   [Full Text] [Related]  

  • 20. Myoclonus and ocular oscillations induced by L-tryptophan.
    Baloh RW; Dietz J; Spooner JW
    Ann Neurol; 1982 Jan; 11(1):95-7. PubMed ID: 7059133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.